CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.91
+0.36 (4.77%)
At close: May 18, 2026, 4:00 PM EDT
7.94
+0.03 (0.38%)
Pre-market: May 19, 2026, 6:27 AM EDT
CorMedix Employees
CorMedix had 191 employees as of December 31, 2025. The number of employees increased by 126 or 193.85% compared to the previous year.
Employees
191
Change (1Y)
126
Growth (1Y)
193.85%
Revenue / Employee
$2,094,524
Profits / Employee
$942,534
Market Cap
620.55M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 191 | 126 | 193.85% | 191 | 0 |
| Dec 31, 2024 | 65 | -18 | -21.69% | 64 | 1 |
| Dec 31, 2023 | 83 | 42 | 102.44% | 82 | 1 |
| Dec 31, 2022 | 41 | 11 | 36.67% | 40 | 1 |
| Dec 31, 2021 | 30 | -5 | -14.29% | 29 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gyre Therapeutics | 625 |
| Allogene Therapeutics | 152 |
| Solid Biosciences | 121 |
| Aclaris Therapeutics | 73 |
| Zevra Therapeutics | 61 |
| Candel Therapeutics | 55 |
| Design Therapeutics | 54 |
| Crescent Biopharma | 44 |
CRMD News
- 3 days ago - Cormedix Therapeutics to Participate in two Upcoming Investor Conferences - GlobeNewsWire
- 4 days ago - CorMedix Earnings Call Transcript: Q1 2026 - Transcripts
- 4 days ago - CorMedix Earnings release: Q1 2026 - Filings
- 4 days ago - CorMedix Quarterly report: Q1 2026 - Filings
- 4 days ago - CorMedix reports Q1 EPS 43c, consensus 33c - TheFly
- 4 days ago - CorMedix raises FY26 revenue view to $325M-$345M from $300M-$320M - TheFly
- 4 days ago - Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 13 days ago - CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026 - GlobeNewsWire